Zilance 40 Tablet contains Azilsartan medoxomil 40mg, an angiotensin II receptor blocker (ARB) indicated for the treatment of hypertension. Azilsartan medoxomil selectively inhibits the binding of angiotensin II to the AT1 receptor, preventing vasoconstriction and aldosterone secretion, thereby reducing blood pressure. This antihypertensive agent is effective in lowering both systolic and diastolic blood pressure, contributing to a decreased risk of cardiovascular events such as stroke and myocardial infarction. Zilance 40 is typically administered once daily, with or without food, and dosage adjustments should be individualized based on patient response and tolerability. It is contraindicated in patients with hypersensitivity to azilsartan or any component of the formulation, and caution is advised in individuals with renal impairment, hepatic dysfunction, or volume depletion. Common adverse effects may include dizziness, fatigue, and hypotension. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy. Zilance 40 should not be used concomitantly with aliskiren in patients with diabetes or renal impairment. This medication offers a well-tolerated and effective option for managing hypertension, improving patient compliance through once-daily dosing and a favorable safety profile.